| Application Number | Application Type | Drug Name | Active Ingredients | Dosage Form/Route | Approval Date | Company |
|---|---|---|---|---|---|---|
| 215570 | ANDA | PALBOCICLIB | PALBOCICLIB | TABLET;ORAL | SYNTHON PHARMS INC | |
| 214758 | ANDA | PALBOCICLIB | PALBOCICLIB | CAPSULE;ORAL | 2023-04-12 | MSN PHARMACEUTICALS INC |
| 213152 | ANDA | PALBOCICLIB | PALBOCICLIB | CAPSULE;ORAL | 2022-03-04 | AIZANT DRUG RESEARCH SOLUTIONS PVT LTD |
| 213107 | ANDA | PALBOCICLIB | PALBOCICLIB | CAPSULE; ORAL | 2021-04-30 | SUN PHARM INDS LTD |
| 213091 | ANDA | PALBOCICLIB | PALBOCICLIB | CAPSULE;ORAL | 2021-08-18 | DR REDDYS LABS LTD |
| 213086 | ANDA | PALBOCICLIB | PALBOCICLIB | CAPSULE;ORAL | 2022-07-07 | EUGIA PHARMA SPECLTS |
| 212436 | NDA | IBRANCE | PALBOCICLIB | TABLET;ORAL | 2019-11-01 | PFIZER |
| 207103 | NDA | IBRANCE | PALBOCICLIB | CAPSULE;ORAL | 2015-02-03 | PFIZER |